MedPath

Clinical study on prevention of new onset atrial fibrillation after pneumonectomy by perioperative Electroacupuncture

Phase 1
Recruiting
Conditions
lung cancer
Registration Number
ITMCTR2100004957
Lead Sponsor
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. No other serious complications occurred in the patients with lung tumor who underwent thoracoscopic lobectomy or pneumonectomy;
2. Aged 60 to 85 years, ASA I-III, no gender restriction;
3. Patients who have completed auxiliary examination and have no immune system diseases;
4. Those who understand and agree to participate in the study and sign the informed consent.

Exclusion Criteria

1. Arrhythmia before operation;
2. The patients with thyroid dysfunction before operation;
3. Taken within 1 month before operation ß- Receptor blockers and digitalis;
4. History of cardiothoracic surgery;
5. The patients with nerve injury of upper limb or lower extremity;
6. Patients with skin infection in the acupoints;
7. Patients with acupuncture and moxibustion treatment history;
8. Patients who cannot cooperate with the completion of the research plan, including language difficulties, infectious diseases and other medical history;
9. Participated in other clinical trials in the past four weeks.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.